Thursday May 16, 2024 | Last Update: May 16, 2024 EDT
Lannett Company, Inc. has announced that it will be acquiring Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A. for $1.23 billion, according to a press release issued by Lannett.
Read more >>
Just In
Most Read
1
2
3
4
5